Diabetes treatments account for about 75 percent of Novo Nordisk's business.
Not exact matches
Biopharmaceutical
treatments, led by haemophilia, make up around 20 percent of Novo's sales, with
diabetes and obesity products
accounting for the remaining 80 percent.
Aside from being a medical condition that negatively affects the quality of life,
diabetes is also very expensive when it comes to
treatment,
accounting for more than 20 percent of health care spending.
Planned Parenthood
accounted for about half of Women's Health Program services last year — mostly in the form of cancer,
diabetes, and STI
treatment, plus high blood pressure screenings, contraception dispersement, and annual checkups.
How does one
account for the previous failure of BFST to improve
treatment adherence and glycemic control for adolescents with type 1
diabetes?